Strides gets USFDA approval for Fluoxetine Tabs 10 mg and 20 mg EP News Bureau Apr 9, 2024 Fluoxetine is an antidepressant used for the treatment of MDD, OCD, bulimia nervosa, panic disorder, with or without agoraphobia
Strides gets tentative USFDA nod for Dolutegravir tablets EP News Bureau Sep 15, 2023 The PEPFAR tentative approval for Strides qualifies the Company to participate in global donor funded programs that procure this…
Ennaid Therapeutics partners with Strides to produce oral COVID‐19 tablet EP News Bureau Jun 14, 2021 Ennaid is ready to seek emergency authorisation from the FDA in the US as well as approval for compassionate use in India
Strides get USFDA nod for Ursodiol capsules EP News Bureau Jan 25, 2021 Ursodiol capsules are indicated for the treatment of patients with Primary Biliary Cirrhosis (PBC)
Strides receives USFDA approval for Prednisone Tablets EP News Bureau Nov 23, 2020 Prednisone is used as an anti-inflammatory or an immunosuppressant medication to treat different conditions such as allergic…